Novo Tests New Obesity Shot With 25% Weight Loss

Novo Nordisk wants to beat its own blockbuster drug. The drugmaker sells Wegovy, but it already has a stronger treatment in the pipeline.

The new shot is called CagriSema. Late study data shows that women taking the drug lost 25% of their body weight. That tops the weight loss from earlier treatments on the market.

Patients take the shot once a week. Novo runs these trials to prepare the drug for global approval.

Weight loss treatments remain a massive business. Better results give patients stronger options and keep the race between drug makers moving fast.

Source: CNBC